1 Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences , Little Rock, Arkansas.
2 Department of Information Systems, University of Arkansas , Fayetteville, Arkansas.
Telemed J E Health. 2017 Oct;23(10):833-841. doi: 10.1089/tmj.2016.0272. Epub 2017 May 5.
Preeclampsia is a hypertensive disorder in pregnancy where a patients' blood pressure and warning signs of worsening disease need to be closely monitored during pregnancy and the postpartum period.
No studies have examined remote patient monitoring using mobile health (m-health) technologies in obstetrical care for women with preeclampsia during the postpartum period. Remote monitoring and m-health technologies can expand healthcare coverage to the patient's home. This may be especially beneficial to patients with chronic conditions who live far from a healthcare facility.
The study was designed to identify and examine the potential factors that influenced use of m-health technology and adherence to monitoring symptoms related to preeclampsia in postpartum women. A sample of 50 women enrolled into the study. Two participants were excluded, leaving a total sample size of 48 women. Users were given m-health devices to monitor blood pressure, weight, pulse, and oxygen saturation over a 2-week period. Nonusers did not receive equipment. The nurse call center monitored device readings and contacted participants as needed. Both groups completed a baseline and follow-up survey.
Women who elected to use the m-health technology on average had lower levels of perceived technology barriers, higher facilitating condition scores, and higher levels of perceived benefits of the technology compared with nonusers. Additionally, among users, there was no statistical difference between full and partial users at follow-up related to perceived ease of use, perceived satisfaction, or perceived benefits.
This study provided a basis for restructuring the management of care for postpartum women with hypertensive disorders through the use of m-health technology.
Mobile health technology may be beneficial during pregnancy and the postpartum period for women with preeclampsia to closely manage and monitor their blood pressure and warning signs of worsening disease.
子痫前期是一种妊娠高血压疾病，患者的血压和疾病恶化的预警信号需要在妊娠和产后期间密切监测。
目前尚未有研究检查过在产后期间使用移动医疗（m-health）技术对患有子痫前期的产妇进行远程患者监测。远程监测和 m-health 技术可以将医疗保健覆盖范围扩大到患者的家庭。对于居住在远离医疗机构的慢性病患者来说，这可能特别有益。
本研究旨在确定并检查影响产后妇女使用 m-health 技术和监测与子痫前期相关症状的潜在因素。研究招募了 50 名女性，其中有 2 名被排除，最终样本量为 48 名女性。为用户提供 m-health 设备，以在 2 周内监测血压、体重、脉搏和血氧饱和度。非使用者未获得设备。护士呼叫中心监测设备读数并根据需要联系参与者。两组均完成了基线和随访调查。
选择使用 m-health 技术的女性平均感知到的技术障碍较低，促进条件评分较高，对技术的感知益处较高，而非使用者则较低。此外，在使用者中，完全和部分使用者在随访时在感知易用性、感知满意度或感知益处方面没有统计学差异。
这项研究为通过使用 m-health 技术来重组管理产后高血压疾病妇女的护理提供了依据。
对于患有子痫前期的女性，m-health 技术可能有助于在妊娠和产后期间密切管理和监测其血压和疾病恶化的预警信号。
